Karen L. Smith Sangamo Therapeutics, Inc (SGMO) insider trading activity

SGMO Quotes by TradingView

Karen L. Smith is of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 77,100 shares of SGMO, which is worth approximately $190,437. The most recent transaction as insider was on Jun 04, 2024, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.1K
0% 3M change
47.98% 12M change
Total Value Held $190,437

Karen L. Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 24.49%
77,100 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
13,900 Added 21.06%
52,100 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 24.65%
38,200 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
8,200 Added 24.19%
25,700 Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
Director
EBS
Emergent BioSolutions Inc. Healthcare
EVP, Chief Medical Officer
TALS
Talaris Therapeutics, Inc. Healthcare
Director
CRTX
Cortexyme, Inc. Healthcare
Chief Medical Officer
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
SKYE
Skye Bioscience, Inc. Healthcare
Director
CNTX
Context Therapeutics Inc. Healthcare
Director
KLS

Karen L. Smith

Gaithersburg,, MD

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGMO